By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


QLT Inc. 

887 Great Northern Way

Vancouver  British Columbia  V5T 4T5  Canada
Phone: n/a Fax: 604-707-7001





Kinetek Pharmaceuticals Inc. 

Company News
QLT Inc. (QLTI) Announces Positive Final Results From Phase 1b Retreatment Trial With Oral Synthetic Cis-Retinoid (QLT091001) In Subjects With LCA Or RP Due To Mutations In RPE65 Or LRAT 9/12/2014 10:41:27 AM
QLT Inc. (QLTI) Announces Adoption Of Advance Notice Policy 8/7/2014 9:03:40 AM
QLT Inc. (QLTI) Announces Second Quarter 2014 Results 8/5/2014 7:59:16 AM
QLT Inc. (QLTI) Announces Publication In The Lancet Of Phase 1b Data For QLT091001 In Leber Congenital Amaurosis Due To LRAT Or RPE65 Mutations 7/14/2014 6:05:34 AM
Auxilium Pharmaceuticals (AUXL) To Merge With Canadian Biotech QLT Inc. (QLTI) 6/26/2014 6:12:05 AM
QLT Inc. (QLTI) Announces First Quarter 2014 Results 4/30/2014 9:50:42 AM
QLT Inc. (QLTI) Announces Fourth Quarter And Year End 2013 Results 2/28/2014 9:25:44 AM
QLT Inc. (QLTI) Announces Positive Preliminary Results From Phase 1b Retreatment Trial Of QLT091001 In Subjects With Leber Congenital Amaurosis And Retinitis Pigmentosa Due To Mutations In LRAT Or RPE65 2/27/2014 9:43:36 AM
QLT Inc. (QLTI) Announces First Patient Dosed In Phase 2a Proof-Of-Concept Trial For QLT091001 In Impaired Dark Adaptation 12/9/2013 9:36:29 AM
QLT Inc. (QLTI) Announces Oral Retinoid Program Clinical And Regulatory Update, And Review Of Strategic Alternatives 11/21/2013 10:01:13 AM